MDBH logo

MDB CAPITAL HOLDINGS LLC

MDBHNASDAQ
πŸ† #3571 by market capUS Equity
$3.07β–² $0.09 (+3.02%)
Market closed Β· at close
1hβ€”
24hβ–² 3.0%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$32M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+7.3%
Slowing
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
7.5x
Fair
Otter Score
49
Weak
No chart data available for MDBH.

Trading Snapshot

Day Range
$3.05 – $3.11
52-Week Range
$2.45 – $4.80
Volume
$3.32B
Avg Volume
$2.64B
Shares Outstanding
10.3M
Next Earnings
Sep 5, 2026

Fundamentals Snapshot

Annual Revenue
$4M
Last Q Revenue
$3M
P/E Ratio
β€”
P/S Ratio
7.5x
EPS (TTM)
$-2.12
Dividend Yield
β€”

Why Investors Own MDBH

  • βœ“High-growth profile β€” revenue up +52.7% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 48% gross margin and 18% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$4Mβ–² +49.8% YoY
Gross Margin (TTM)
48.4%β–² +2.8% YoY
Operating Income (TTM)
$792,170β–² +49.8% YoY
Free Cash Flow (TTM)
$779,324β–² +49.8% YoY

About MDB CAPITAL HOLDINGS LLC

MDB Capital Holdings, LLC functions primarily as a broker-dealer through its subsidiary operations. The company's activities are divided into two main areas: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service division provides comprehensive broker-dealer services, focusing on arranging private and public securities offerings, and furnishing research for investment banking due diligence. Meanwhile, the Technology Development division is engaged in the advancement of synthetic biology technology. MDB Capital Holdings, LLC was established in 1997 and is based in Addison, Texas.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
49/100

Analyst Price Target

β“˜
Average Target
$3.63
β–² +18.3% Upside
High Target$4.55
Low Target$3.30
Based on 39 analysts

Latest News & Updates